Literature DB >> 21482483

Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation.

Gunter Rappl1, Stefan Pabst, Dagmar Riemann, Annette Schmidt, Claudia Wickenhauser, Wolfgang Schütte, Andreas A Hombach, Barbara Seliger, Christian Grohé, Hinrich Abken.   

Abstract

Sarcoidosis can evolve into a chronic disease with persistent granulomas accompanied by progressive fibrosis. While an unlimited inflammatory response suggests an impaired immune control in sarcoid lesions, it stands in contrast to the massive infiltration with CD4(+)CD25(high)FoxP3(+) regulatory T cells. We here revealed that those Treg cells in affected lung lesions were mainly derived from activated natural Treg cells with GARP (LRRC32)-positive phenotype but exhibited reduced repressor capacities despite high IL-10 and TGF-beta 1 levels. The repressive capacity of blood Treg cells, in contrast, was not impaired compared to age-matched healthy donors. Treg derived cells in granuloma lesions have undergone extensive rounds of amplifications indicated by shortened telomeres compared to blood Treg cells of the same patient. Lesional Treg derived cells moreover secreted pro-inflammatory cytokines including IL-4 which sustains granuloma formation through fibroblast amplification and the activation of mast cells, the latter indicated by the expression of membrane-bound oncostatin M.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21482483     DOI: 10.1016/j.clim.2011.03.015

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  25 in total

1.  Sarcoidosis of the central nervous system: clinical features, imaging, and CSF results.

Authors:  Desmond P Kidd
Journal:  J Neurol       Date:  2018-06-19       Impact factor: 4.849

2.  Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis.

Authors:  A Verwoerd; D Hijdra; A D M Vorselaars; H A Crommelin; C H M van Moorsel; J C Grutters; A M E Claessen
Journal:  Clin Exp Immunol       Date:  2016-07-12       Impact factor: 4.330

Review 3.  Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.

Authors:  Johan Grunewald; Paolo Spagnolo; Jan Wahlström; Anders Eklund
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 4.  Etiologies of Sarcoidosis.

Authors:  Edward S Chen; David R Moller
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 5.  Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.

Authors:  Amy S McKee; Shaikh M Atif; Michael T Falta; Andrew P Fontenot
Journal:  J Immunol       Date:  2022-04-15       Impact factor: 5.426

6.  Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis.

Authors:  Kyra A Oswald-Richter; Bradley W Richmond; Nicole A Braun; Joan Isom; Susamma Abraham; Thyneice R Taylor; John M Drake; Daniel A Culver; David S Wilkes; Wonder P Drake
Journal:  J Immunol       Date:  2013-04-29       Impact factor: 5.422

Review 7.  Epigenetics in immune-mediated pulmonary diseases.

Authors:  Yu Liu; Hui Li; Tao Xiao; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

8.  Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis.

Authors:  G Cooke; I Kamal; M Strengert; E Hams; L Mawhinney; A Tynan; C O'Reilly; D N O'Dwyer; S L Kunkel; U G Knaus; D C Shields; D R Moller; A G Bowie; P G Fallon; C M Hogaboam; M E Armstrong; S C Donnelly
Journal:  QJM       Date:  2018-04-01

Review 9.  Sarcoidosis: Immunopathogenesis and Immunological Markers.

Authors:  Wei Sheng Joshua Loke; Cristan Herbert; Paul S Thomas
Journal:  Int J Chronic Dis       Date:  2013-07-25

10.  Impaired survival of regulatory T cells in pulmonary sarcoidosis.

Authors:  Caroline E Broos; Menno van Nimwegen; Alex Kleinjan; Bregje ten Berge; Femke Muskens; Johannes C C M in 't Veen; Jouke T Annema; Bart N Lambrecht; Henk C Hoogsteden; Rudi W Hendriks; Mirjam Kool; Bernt van den Blink
Journal:  Respir Res       Date:  2015-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.